PTCT - PTC Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.16B
Enterprise Value 32.12B
Trailing P/E N/A
Forward P/E 1-51.25
PEG Ratio (5 yr expected) 11.61
Price/Sales (ttm)8.14
Price/Book (mrq)5.32
Enterprise Value/Revenue 38.00
Enterprise Value/EBITDA 6-30.88

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin -48.38%
Operating Margin (ttm)-35.75%

Management Effectiveness

Return on Assets (ttm)-7.83%
Return on Equity (ttm)-50.51%

Income Statement

Revenue (ttm)264.73M
Revenue Per Share (ttm)5.68
Quarterly Revenue Growth (yoy)10.60%
Gross Profit (ttm)252.06M
EBITDA -68.56M
Net Income Avi to Common (ttm)-128.08M
Diluted EPS (ttm)-2.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)227.59M
Total Cash Per Share (mrq)3.9
Total Debt (mrq)153.01M
Total Debt/Equity (mrq)43.63
Current Ratio (mrq)1.92
Book Value Per Share (mrq)6.93

Cash Flow Statement

Operating Cash Flow (ttm)-27.64M
Levered Free Cash Flow (ttm)19.06M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.47
52-Week Change 317.58%
S&P500 52-Week Change 37.11%
52 Week High 352.95
52 Week Low 324.60
50-Day Moving Average 333.46
200-Day Moving Average 336.13

Share Statistics

Avg Vol (3 month) 3877.27k
Avg Vol (10 day) 3649.48k
Shares Outstanding 558.4M
Float 56.73M
% Held by Insiders 12.84%
% Held by Institutions 185.52%
Shares Short (Feb 28, 2019) 45.73M
Short Ratio (Feb 28, 2019) 46.54
Short % of Float (Feb 28, 2019) 414.73%
Short % of Shares Outstanding (Feb 28, 2019) 49.81%
Shares Short (prior month Jan 31, 2019) 45.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A